BSX vs GECCG
Boston Scientific Corp (BSX) versus Great Elm Capital Corp. 7.75% Notes Due 2030 (GECCG) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Great Elm Capital Corp. 7.75% Notes Due 2030 (GECCG) common stock listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
GECCG does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. GECCG currently screens at market cap $0.
Not investment advice. Open the BSX and GECCG stock pages for the full models.
Not investment advice.